GILEAD SCIENCES, INC. Increase (Decrease) in Accrued Liabilities
GILEAD SCIENCES, INC. (GILD) reported Increase (Decrease) in Accrued Liabilities of -$364.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-06
- GILEAD SCIENCES, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $338.00M.
- GILEAD SCIENCES, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$702.00M.
- GILEAD SCIENCES, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$395.00M, a 229.51% decline year-over-year.
- GILEAD SCIENCES, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $811.00M, a 433.55% increase year-over-year.
- GILEAD SCIENCES, INC. increase (decrease) in accrued liabilities for fiscal 2025 was $6.00M, a 94.44% decline from fiscal 2024.
- GILEAD SCIENCES, INC. increase (decrease) in accrued liabilities for fiscal 2024 was $108.00M, a 76.42% decline from fiscal 2023.
- GILEAD SCIENCES, INC. increase (decrease) in accrued liabilities for fiscal 2023 was $458.00M.
- GILEAD SCIENCES, INC. increase (decrease) in accrued liabilities for fiscal 2022 was -$775.00M, a 212.48% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $338.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$364.00M 10-Q · filed 2026-08-06 | -$759.00M derived: sum of 3 quarters · filed 2026-08-06 | $52.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$702.00M 10-Q · filed 2026-05-07 | -$1.10B derived: sum of 2 quarters · filed 2026-05-07 | -$286.00M derived: sum of 3 quarters · filed 2026-05-07 | -$452.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$395.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $416.00M derived: sum of 2 quarters · filed 2026-02-24 | $250.00M derived: sum of 3 quarters · filed 2026-08-06 | $6.00M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $811.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $645.00M derived: sum of 2 quarters · filed 2026-08-06 | $401.00M 10-Q · filed 2025-11-07 | $706.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$166.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$410.00M 10-Q · filed 2026-08-06 | -$105.00M derived: sum of 3 quarters · filed 2026-08-06 | $47.00M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$244.00M 10-Q · filed 2026-05-07 | $61.00M derived: sum of 2 quarters · filed 2026-05-07 | $213.00M derived: sum of 3 quarters · filed 2026-05-07 | $39.00M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $305.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $457.00M derived: sum of 2 quarters · filed 2026-02-24 | $283.00M derived: sum of 3 quarters · filed 2026-02-24 | $108.00M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $152.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$22.00M derived: sum of 2 quarters · filed 2025-11-07 | -$197.00M 10-Q · filed 2025-11-07 | $120.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | -$174.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$349.00M 10-Q · filed 2025-08-07 | -$32.00M derived: sum of 3 quarters · filed 2026-02-24 | $18.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | -$175.00M 10-Q · filed 2025-05-07 | $142.00M derived: sum of 2 quarters · filed 2026-02-24 | $192.00M derived: sum of 3 quarters · filed 2026-02-24 | $826.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $317.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $367.00M derived: sum of 2 quarters · filed 2026-02-24 | $1.00B derived: sum of 3 quarters · filed 2026-02-24 | $458.00M 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $50.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $684.00M derived: sum of 2 quarters · filed 2024-11-12 | $141.00M 10-Q · filed 2024-11-12 | $497.00M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-06-30 | $634.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $91.00M 10-Q · filed 2024-08-08 | $447.00M derived: sum of 3 quarters · filed 2025-02-28 | $611.00M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | -$543.00M 10-Q · filed 2024-05-08 | -$187.00M derived: sum of 2 quarters · filed 2025-02-28 | -$23.00M derived: sum of 3 quarters · filed 2025-02-28 | $339.00M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $356.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $520.00M derived: sum of 2 quarters · filed 2025-02-28 | $882.00M derived: sum of 3 quarters · filed 2025-02-28 | -$775.00M 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | $164.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $526.00M derived: sum of 2 quarters · filed 2023-11-07 | -$1.13B 10-Q · filed 2023-11-07 | $409.00M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-06-30 | $362.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$1.29B 10-Q · filed 2023-08-04 | $245.00M derived: sum of 3 quarters · filed 2024-02-23 | $107.00M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-03-31 | -$1.66B 10-Q · filed 2023-05-03 | -$117.00M derived: sum of 2 quarters · filed 2024-02-23 | -$255.00M derived: sum of 3 quarters · filed 2024-02-23 | -$230.00M derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2021-12-31 | $1.54B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $1.40B derived: sum of 2 quarters · filed 2024-02-23 | $1.43B derived: sum of 3 quarters · filed 2024-02-23 | $689.00M 10-K · filed 2024-02-23 | ||||
| 2021-09-30 | -$138.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$113.00M derived: sum of 2 quarters · filed 2022-11-02 | -$851.00M 10-Q · filed 2022-11-02 | -$269.00M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $25.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$713.00M 10-Q · filed 2022-08-08 | -$131.00M derived: sum of 3 quarters · filed 2023-02-22 | $14.00M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | -$738.00M 10-Q · filed 2022-05-04 | -$156.00M derived: sum of 2 quarters · filed 2023-02-22 | -$11.00M derived: sum of 3 quarters · filed 2023-02-22 | $452.00M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $582.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $727.00M derived: sum of 2 quarters · filed 2023-02-22 | $1.19B derived: sum of 3 quarters · filed 2023-02-22 | $640.00M 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | $145.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $608.00M derived: sum of 2 quarters · filed 2021-11-03 | $58.00M 10-Q · filed 2021-11-03 | $393.00M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-06-30 | $463.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$87.00M 10-Q · filed 2021-08-05 | $248.00M derived: sum of 3 quarters · filed 2022-02-23 | $64.00M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-03-31 | -$550.00M 10-Q · filed 2021-05-06 | -$215.00M derived: sum of 2 quarters · filed 2022-02-23 | -$399.00M derived: sum of 3 quarters · filed 2022-02-23 | -$522.00M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2019-12-31 | $335.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $151.00M derived: sum of 2 quarters · filed 2022-02-23 | $28.00M derived: sum of 3 quarters · filed 2022-02-23 | -$389.00M 10-K · filed 2022-02-23 | ||||
| 2019-09-30 | -$184.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$307.00M derived: sum of 2 quarters · filed 2020-11-04 | -$724.00M 10-Q · filed 2020-11-04 | -$914.00M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | -$123.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$540.00M 10-Q · filed 2020-08-06 | -$488.00M 10-Q · filed 2019-08-06 | -$730.00M derived: sum of 3 quarters · filed 2021-02-25 | -$1.37B derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-03-31 | -$417.00M 10-Q · filed 2020-05-06 | -$607.00M derived: sum of 2 quarters · filed 2021-02-25 | -$1.25B derived: sum of 3 quarters · filed 2021-02-25 | -$1.09B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | -$190.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$833.00M derived: sum of 2 quarters · filed 2021-02-25 | -$678.00M derived: sum of 3 quarters · filed 2021-02-25 | -$514.00M 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | -$643.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$488.00M derived: sum of 2 quarters · filed 2019-11-05 | -$324.00M 10-Q · filed 2019-11-05 | -$118.00M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-06-30 | $155.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $319.00M 10-Q · filed 2019-08-06 | $525.00M derived: sum of 3 quarters · filed 2020-02-25 | -$150.00M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-03-31 | $164.00M 10-Q · filed 2019-05-08 | $370.00M derived: sum of 2 quarters · filed 2020-02-25 | -$305.00M derived: sum of 3 quarters · filed 2020-02-25 | $23.00M derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2017-12-31 | $206.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$469.00M derived: sum of 2 quarters · filed 2020-02-25 | -$141.00M derived: sum of 3 quarters · filed 2020-02-25 | -$818.00M 10-K · filed 2020-02-25 | ||||
| 2017-09-30 | -$675.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$347.00M derived: sum of 2 quarters · filed 2018-11-06 | -$1.02B 10-Q · filed 2018-11-06 | -$1.79B derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | $328.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | -$349.00M 10-Q · filed 2018-08-06 | -$1.12B derived: sum of 3 quarters · filed 2019-02-26 | -$893.00M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | -$677.00M 10-Q · filed 2018-05-09 | -$1.44B derived: sum of 2 quarters · filed 2019-02-26 | -$1.22B derived: sum of 3 quarters · filed 2019-02-26 | -$732.00M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | -$767.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$544.00M derived: sum of 2 quarters · filed 2019-02-26 | -$55.00M derived: sum of 3 quarters · filed 2019-02-26 | $305.00M 10-K · filed 2019-02-26 | $425.00M 10-K · filed 2017-02-27 | |||
| 2016-09-30 | $223.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $712.00M derived: sum of 2 quarters · filed 2017-11-07 | $1.07B 10-Q · filed 2017-11-07 | $1.06B 10-Q · filed 2016-11-07 | $1.80B derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-06-30 | $489.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $849.00M 10-Q · filed 2017-08-07 | $876.00M 10-Q · filed 2016-08-05 | $1.57B derived: sum of 3 quarters · filed 2018-02-27 | $2.15B derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-03-31 | $360.00M 10-Q · filed 2017-05-10 | $195.00M 10-Q · filed 2016-05-06 | $1.08B derived: sum of 2 quarters · filed 2018-02-27 | $1.66B derived: sum of 3 quarters · filed 2018-02-27 | $2.17B derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2015-12-31 | $725.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $1.30B derived: sum of 2 quarters · filed 2018-02-27 | $1.81B derived: sum of 3 quarters · filed 2018-02-27 | $3.34B 10-K · filed 2018-02-27 | $2.63B 10-K · filed 2016-02-24 | |||
| 2015-09-30 | $572.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $1.09B derived: sum of 2 quarters · filed 2016-11-07 | $2.62B 10-Q · filed 2016-11-07 | $3.37B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $515.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $2.04B 10-Q · filed 2016-08-05 | $2.80B derived: sum of 3 quarters · filed 2017-02-27 | $3.18B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $1.53B 10-Q · filed 2016-05-06 | $2.29B derived: sum of 2 quarters · filed 2017-02-27 | $2.67B derived: sum of 3 quarters · filed 2017-02-27 | $3.38B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $757.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $1.14B derived: sum of 2 quarters · filed 2017-02-27 | $1.85B derived: sum of 3 quarters · filed 2017-02-27 | $2.01B 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $379.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $1.09B derived: sum of 2 quarters · filed 2015-11-04 | $1.26B 10-Q · filed 2015-11-04 | $1.26B 10-Q · filed 2014-11-05 | $1.35B derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2014-06-30 | $711.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $877.00M 10-Q · filed 2015-08-05 | $877.06M 10-Q · filed 2014-08-04 | $970.68M derived: sum of 3 quarters · filed 2016-02-24 | $956.81M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2014-03-31 | $166.00M 10-Q · filed 2015-05-08 | $166.26M 10-Q · filed 2014-05-07 | $259.68M derived: sum of 2 quarters · filed 2016-02-24 | $245.81M derived: sum of 3 quarters · filed 2016-02-24 | $310.98M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2013-12-31 | $93.68M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $79.81M derived: sum of 2 quarters · filed 2016-02-24 | $144.98M derived: sum of 3 quarters · filed 2016-02-24 | $312.00M 10-K · filed 2016-02-24 | $311.63M 10-K · filed 2014-02-25 | |||
| 2013-09-30 | -$13.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $51.30M derived: sum of 2 quarters · filed 2014-11-05 | $218.32M 10-Q · filed 2014-11-05 | $265.76M 10-Q · filed 2013-10-31 | $137.49M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2013-06-30 | $65.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $232.19M 10-Q · filed 2014-08-04 | $249.63M 10-Q · filed 2013-08-01 | $151.36M derived: sum of 3 quarters · filed 2015-02-25 | $272.25M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2013-03-31 | $167.02M 10-Q · filed 2014-05-07 | $173.04M 10-Q · filed 2013-05-08 | $86.19M derived: sum of 2 quarters · filed 2015-02-25 | $207.07M derived: sum of 3 quarters · filed 2015-02-25 | $373.62M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | -$80.83M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $40.06M derived: sum of 2 quarters · filed 2015-02-25 | $206.60M derived: sum of 3 quarters · filed 2015-02-25 | $317.00M 10-K · filed 2015-02-25 | $386.06M 10-K · filed 2013-02-27 | |||
| 2012-09-30 | $120.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $287.43M derived: sum of 2 quarters · filed 2013-10-31 | $397.83M 10-Q · filed 2013-10-31 | $583.45M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | $166.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $276.94M 10-Q · filed 2013-08-01 | $462.56M derived: sum of 3 quarters · filed 2014-02-25 | $470.51M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | $110.40M 10-Q · filed 2013-05-08 | $296.02M derived: sum of 2 quarters · filed 2014-02-25 | $303.97M derived: sum of 3 quarters · filed 2014-02-25 | $341.10M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $185.62M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $193.57M derived: sum of 2 quarters · filed 2014-02-25 | $230.70M derived: sum of 3 quarters · filed 2014-02-25 | $292.11M 10-K · filed 2014-02-25 | $300.59M 10-K · filed 2012-02-23 | |||
| 2011-09-30 | $7.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $45.08M derived: sum of 2 quarters · filed 2012-11-06 | $106.49M 10-Q · filed 2012-11-06 | $129.44M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | $37.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01 | $98.54M 10-Q · filed 2012-08-01 | $121.49M derived: sum of 3 quarters · filed 2013-02-27 | $187.51M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-03-31 | $61.41M 10-Q · filed 2012-05-04 | $84.36M derived: sum of 2 quarters · filed 2013-02-27 | $150.39M derived: sum of 3 quarters · filed 2013-02-27 | $162.71M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-31 | $22.95M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $88.97M derived: sum of 2 quarters · filed 2013-02-27 | $101.30M derived: sum of 3 quarters · filed 2013-02-27 | $120.06M 10-K · filed 2013-02-27 | ||||
| 2010-09-30 | $66.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $78.35M derived: sum of 2 quarters · filed 2011-11-04 | $97.11M 10-Q · filed 2011-11-04 | $126.81M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-06-30 | $12.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-05 | $31.09M 10-Q · filed 2011-08-05 | $60.79M derived: sum of 3 quarters · filed 2012-02-23 | $156.06M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-03-31 | $18.77M 10-Q · filed 2011-05-09 | $48.47M derived: sum of 2 quarters · filed 2012-02-23 | $143.74M derived: sum of 3 quarters · filed 2012-02-23 | $117.79M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2009-12-31 | $29.70M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $124.97M derived: sum of 2 quarters · filed 2012-02-23 | $99.02M derived: sum of 3 quarters · filed 2012-02-23 | $109.03M 10-K · filed 2012-02-23 | ||||
| 2009-09-30 | $95.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $69.33M derived: sum of 2 quarters · filed 2010-11-08 | $79.33M 10-Q · filed 2010-11-08 | $120.83M derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-06-30 | -$25.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-09 | -$15.95M 10-Q · filed 2010-08-09 | $25.56M derived: sum of 3 quarters · filed 2011-02-28 | $97.36M derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-03-31 | $10.00M 10-Q · filed 2010-05-10 | $51.51M derived: sum of 2 quarters · filed 2011-02-28 | $123.30M derived: sum of 3 quarters · filed 2011-02-28 | |||||
| 2008-12-31 | $41.51M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $113.30M derived: sum of 2 quarters · filed 2011-02-28 | $136.28M 10-K · filed 2011-02-28 | |||||
| 2008-09-30 | $71.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | $94.77M 10-Q · filed 2009-11-05 | ||||||
| 2008-06-30 | $22.97M 10-Q · filed 2009-08-05 | |||||||
| 2007-12-31 | $80.09M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |